These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1185 related articles for article (PubMed ID: 15001199)

  • 1. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study].
    Pannier B; Guérin A; London G; Asmar R; Safar M;
    Arch Mal Coeur Vaiss; 2002 Sep; 95 Spec No 6():11-6. PubMed ID: 12407781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of slow-release indapamide and perindopril compared with amlodipine on 24-hour blood pressure and left ventricular mass in hypertensive patients of African ancestry.
    Libhaber EN; Libhaber CD; Candy GP; Sliwa K; Kachope J; Hlatshwayo NM; Puane MO; Woodiwiss AJ; Norton GR; Essop MR; Sareli P
    Am J Hypertens; 2004 May; 17(5 Pt 1):428-32. PubMed ID: 15110902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
    Asmar RG; London GM; O'Rourke ME; Safar ME;
    Hypertension; 2001 Oct; 38(4):922-6. PubMed ID: 11641310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arterial stiffness, wave reflections and myocardial protection: the REASON project].
    London GM
    Drugs; 2003; 63 Spec No 1():9-17. PubMed ID: 12708879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects.
    Amar J; Ruidavets JB; Peyrieux JC; Mallion JM; Ferrières J; Safar ME; Chamontin B
    Hypertension; 2005 Jul; 46(1):151-5. PubMed ID: 15956115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the angiotensin-converting enzyme inhibitor perindopril on 24-hour blood pressure in patients with lacunar infarction: comparison between dippers and non-dippers.
    Yamamoto Y; Oiwa K; Hayashi M; Ohara T; Muranishi M
    Hypertens Res; 2005 Jul; 28(7):571-8. PubMed ID: 16335885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs.
    Jin Y; Thijs L; Richart T; Li Y; Dolan E; Wang JG; Protogerou A; O'Brien E; Staessen JA; Safar ME
    Hypertens Res; 2011 Apr; 34(4):489-95. PubMed ID: 21228786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.